Our data showed a trend of declining for all kinds of antibodies since the peak levels at 0.75-month upon disease onset ( Figure 2 A,B; Supplementary Figure 1M-N).
← all excerpts
A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity.
2
—
—
The sentences
Similarly, SARS-CoV-2 nAb titres in the mild or severe groups largely reassembled the patterns of RBD-IgG ELISA, showing a decreasing trend and a higher level in severe patients ( Figure 2 K).